This study is a retrospective epidemiological assessment of bacterial species isolated from a cohort of out-patients with diabetic foot infections referred to our “Diabetic Foot Unit” over one year, with particular attention to index pathogens, as identified by the EARS […]
The aim of this work was to evaluate, via foot and ankle MRI, the outcomes of the use of a bone substitute (CERAMENT™|G) and the growth of native bone in the treatment of osteomyelitis (OM) of the diabetic foot. In […]
Aim of this work was to evaluate the efficacy of a new antibiotic bone substitute, Calcium Sulphate Hemihydrate + Hydroxyapatite + Gentamicin Sulfate (CSH + HA + GS), in the treatment of osteomyelitis (OM) in diabetic foot. From June 2013 […]
Diabetic patients are at increased risk of developing foot ulcers which may cause bone infections associated with a high probability of both amputation and mortality. Therefore, prompt diagnosis and adequate treatment are of key importance. In our Diabetic Foot Unit, […]
Since July 2013 our group has been using an antibiotic bone substitute, composed of calcium sulphate, hydroxyapatite and gentamicin sulphate (CSH + HA + GS), in the treatment of osteomyelitis (OM) in diabetic foot. The aim of this work was […]
Medical doctor and endocrinologist, specialised in the treatment of diabetes and of the diabetic foot.
PhD in hypertension and prevention of cardiovascular risk.
Head of the Diabetic Foot Unit of the Abano Polyclinic (Abano Terme, Padua, Italy).
